SCHEMBL29989984

SCHEMBL29989984

CC1(C)CCc2c(-c3cc4ccc(C(=O)N5CC6(CNC6)C5)cc4[nH]3)n[nH]c2C1

nearest known ligand 0.51

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
▸ ITK Q08881 7/20 0.51
▸ PIP5K1C O60331 10/20 0.40
▸ FLT3 P36888 1/20 0.39
▸ GPR183 P32249 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24671251 1.00 ITK (0.51) ITKPIP5K1CFLT3GPR183
SCHEMBL25190483 0.94 ITK (0.49) ITKPIP5K1CFLT3GPR183
SCHEMBL29990522 0.89 ITK (0.53) ITKPIP5K1CFLT3GPR183
SCHEMBL24670928 0.89 ITK (0.53) ITKPIP5K1CFLT3GPR183
SCHEMBL30863357 0.88 ITK (0.54) ITKPIP5K1C
SCHEMBL24670722 0.87 ITK (0.51) ITKPIP5K1C
SCHEMBL30066458 0.87 ITK (0.51) ITKPIP5K1C
SCHEMBL25190175 0.87 ITK (0.47) ITKPIP5K1C
SCHEMBL12027720 0.87 ITK (0.53) ITKPIP5K1C
SCHEMBL12027721 0.86 ITK (0.62) ITKPIP5K1CFLT3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117916231-A Compounds for inhibiting or degrading target proteins, compositions comprising the same, methods of making and methods of using the same 纽力克斯治疗公司 2024-04-19 — — CN disclosed
EP-4334302-A1 COMPOUNDS FOR INHIBITING OR DEGRADING TARGET PROTEINS, COMPOSITIONS, COMPRISING THE SAME, METHODS OF THEIR MAKING, AND METHODS OF THEIR USE Nurix Therapeutics, Inc. (US) 2024-03-13 — — EP disclosed
WO-2022235698-A1 COMPOUNDS FOR INHIBITING OR DEGRADING TARGET PROTEINS, COMPOSITIONS, COMPRISING THE SAME, METHODS OF THEIR MAKING, AND METHODS OF THEIR USE NURIX THERAPEUTICS, INC. (US) 2022-11-10 — — WO disclosed
Send feedback